Cancer drugs are the hardest to get FDA approvals and very expensive trials. That would be a very, very, long wait. IPIX has a cancer drug called Kevetrin and it has been shown to activate the P53 gene which is huge. It's practically been shelved because they are currently working on Brilacidin.